Total submissions: 8
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Gene |
RCV000395206 | SCV000329374 | likely benign | not provided | 2021-05-27 | criteria provided, single submitter | clinical testing | This variant is associated with the following publications: (PMID: 32883383, 30821013, 29870100, 30662450, 26740507, 25339316, 31872048) |
Invitae | RCV000559220 | SCV000652949 | likely benign | Developmental and epileptic encephalopathy, 14; Autosomal dominant nocturnal frontal lobe epilepsy 5 | 2024-01-11 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV002311398 | SCV000846845 | likely benign | Inborn genetic diseases | 2018-02-14 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Genome- |
RCV002270197 | SCV002553673 | likely benign | Developmental and epileptic encephalopathy, 14 | 2022-03-15 | criteria provided, single submitter | clinical testing | |
Genome- |
RCV002270198 | SCV002553674 | likely benign | Autosomal dominant nocturnal frontal lobe epilepsy 5 | 2022-03-15 | criteria provided, single submitter | clinical testing | |
Fulgent Genetics, |
RCV000559220 | SCV002806311 | likely benign | Developmental and epileptic encephalopathy, 14; Autosomal dominant nocturnal frontal lobe epilepsy 5 | 2021-10-11 | criteria provided, single submitter | clinical testing | |
Ce |
RCV000395206 | SCV004158994 | benign | not provided | 2022-09-01 | criteria provided, single submitter | clinical testing | KCNT1: BS1, BS2 |
Prevention |
RCV003977722 | SCV004793906 | likely benign | KCNT1-related condition | 2023-08-24 | criteria provided, single submitter | clinical testing | This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). |